What do docking and QSAR tell us about the design of HIV-1 reverse transcriptase nonnucleoside inhibitors?
Crossref DOI link: https://doi.org/10.1007/s00894-017-3489-3
Published Online: 2017-10-19
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paneth, Agata
PÅ‚onka, Wojciech
Paneth, Piotr http://orcid.org/0000-0002-3091-8387
Funding for this research was provided by:
Polish National Science Centre (2011/02/A/ST4/00246)
License valid from 2017-10-19